MYCOPLASM S 360 

 Mycophenolate Sodium (360mg)

Introduction to Mycophenolate Sodium (360mg)

Mycophenolate Sodium, available as MYCOPLASM S 360, is a medication used primarily for preventing organ rejection in patients who have undergone kidney, liver, or heart transplants. It belongs to a class of medications known as immunosuppressants.

• Usage: Prevents organ rejection post-transplant
• Form: 360mg enteric-coated tablets

How MYCOPLASM S 360 Works

MYCOPLASM S 360 suppresses the immune system to prevent it from attacking the transplanted organ. It inhibits the proliferation of T and B lymphocytes, which are key cells in the immune response.

• Mechanism of Action: Inhibits inosine monophosphate dehydrogenase
• Effect: Reduces the activity of the immune system

Uses of MYCOPLASM S 360

The primary use of MYCOPLASM S 360 is to maintain immunosuppression in transplant patients to prevent organ rejection. It may also be used for other immune-related conditions as prescribed by a healthcare provider.

• Transplant Rejection Prevention: Essential for kidney, liver, and heart transplant patients
• Autoimmune Diseases: Sometimes used off-label for conditions like lupus nephritis

Dosage and Administration

The dosage of MYCOPLASM S 360 must be carefully managed and is often adjusted based on therapeutic response and clinical condition.

• Initial Dosage: Tailored according to individual patient needs and type of transplant
• Administration: Taken on an empty stomach, 1 hour before or 2 hours after meals

Side Effects of Mycophenolate Sodium

As with any potent medication, MYCOPLASM S 360 can have side effects, which range from mild to severe.

• Common Side Effects: Gastrointestinal disturbances, headaches, and increased risk of infections
• Serious Side Effects: Leukopenia, anemia, and increased risk of malignancies

Interactions with Other Medications

MYCOPLASM S 360 can interact with various other drugs, potentially affecting its effectiveness or leading to adverse effects.

• Significant Interactions: Antacids containing magnesium and aluminum, other immunosuppressants
• Monitoring: Blood levels of the drug and complete blood count should be monitored regularly

Conclusion

Mycophenolate Sodium (MYCOPLASM S 360) is a critical medication for transplant recipients, helping to prevent organ rejection and maintain long-term transplant success. Patients should adhere strictly to their prescribed regimen and attend all follow-up appointments to monitor for side effects and ensure the medication's efficacy and safety. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics,

General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.

 For further information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

 BUY NOW